Karen L. Shoos's most recent trade in Celldex Therapeutics Inc. was a trade of 16,500 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Karen L. Shoos | Director | 13 Jun 2024 | 16,500 | 16,500 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Celldex Therapeutics Inc. | Karen L. Shoos | Director | 15 Jun 2023 | 11,300 | 11,300 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Celldex Therapeutics Inc. | Karen L. Shoos | Director | 16 Jun 2022 | 13,600 | 13,600 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Celldex Therapeutics Inc. | Karen L. Shoos | Director | 17 Jun 2021 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) |